ArticleBJUI compass2025
Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia.
Article in BJUI compass, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia.BJUI compass · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe a single academic centre experience in the establishment of Multidisciplinary Meetings (MDM) for the management of male non-neurogenic Lower Urinary Tract Symptoms (LUTS) and Benign Prostate Hyperplasia (BPH). Materials and methods: Retrospective analysis of all the cases discussed in MDM for LUTS/BPH in our academic centre over a year, and analysis of the implementation rates, reasons for failure of implementation and discrepancies between the proposal and the final decision. Results: Over one year, 108 cases were discussed. The implementation rate of the recommendation was 71% (77/108). The reasons for the failure of implementation of the recommendation were patient preference in 6 (5%), lost to follow-up in 13 (12%), consultant decision in 4 (4%), patient deterioration or new comorbidities in 2 (2%), improvement of LUTS symptoms in 4 (4%) and the suggested technique was not available for technical reasons in 1 (1%). The consultant's proposal was validated in 98 cases (90.7%) and a different decision was made in 9 cases (8.3%). Conclusion: The establishment of a MDM for male LUTS/BPH is feasible and could contribute to the improvement of the management of patients. Further studies are needed to evaluate all its aspects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.